Steinman R M. Decisions about dendritic cells: past, present, and future[J]. Annu Rev Immunol, 2012, 30: 1-22. [2]Tel J, Aarntzen E H, Baba T, et al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients[J]. Cancer Res, 2013, 73(3): 1063-1075. [3]Schreiber R D, Old L J, Smyth M J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion[J]. Science, 2011, 331(6024): 1565-1570. [4]Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells[J]. Nat Rev Cancer, 2012, 12(4): 265-277. [5]Radford K J, Tullett K M, Lahoud M H. Dendritic cells and cancer immunotherapy [J]. Curr Opin Immunol, 2014, 27: 26-32. [6]Katz T, Avivi I, Benyamini N, et al. Dendritic cell cancer vaccines: from the bench to the bedside[J]. Rambam Maimonides Med J, 2014, 5(4): e0024. [7]Zeng Z, Xu X, Zhang Y, et al. Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton[J]. Cell Motil Cytoskeleton, 2007, 64(3): 186-198. [8]Xu X, Zeng Z, Yao W, et al. Biomechanical alterations of dendritic cells by co-culturing with K562 CML cells and their potential role in immune escape [J]. J Biomech, 2010, 43(12): 2339-2347. [9]曾柱, 龙金华. 肝癌细胞对树突状细胞线粒体功能的抑制作用[J]. 第三军医大学学报, 2010, 32(9): 930-933. [10]曾柱, 龙金华, 陈琳. 肝癌细胞微环境对不同分化阶段树突状细胞功能状态的影响[J]. 重庆医科大学学报, 2010, 35(12): 1773-1778. [11]Holton S E, Walsh M J, Bhargava R. Subcellular localization of early biochemical transformations in cancer-activated fibroblasts using infrared spectroscopic imaging[J]. Analyst, 2011, 136(14): 2953-2958. [12]Ramesh J, Salman A, Hammody Z, et al. Application of FTIR microscopy for the characterization of malignancy: H-ras transfected murine fibroblasts as an example[J]. J Biochem Biophys Methods, 2001, 50(1): 33-42. [13]Campello S, Lacalle R A, Bettella M, et al. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics[J]. J Exp Med, 2006, 203(13): 2879-2886. [14]Wang X, Li H, Ding S. The effects of NAD+ on apoptotic neuronal death and mitochondrial biogenesis and function after glutamate excitotoxicity[J]. Int J Mol Sci, 2014, 15(11): 20449-20468. [15]Kuznetsov A V, Margreiter R. Heterogeneity of mitochondrial and mitochondrial function within cells as another level of mitochondrial complexity[J]. Int J Mol Sci, 2009, 10(4): 1911-1929. [16]Lee W K, Dittmar T. Cytosolic calcium measurements in renal epithelial cells by flow cytometry[J]. J Vis Exp, 2014(92): e51857. [17]Hsu M M, Huang P Y, Lee Y C, et al. FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer[J]. Int J Mol Sci, 2014, 15(10): 17963-17973.
[2]
杨永长,传良敏,黄文芳,等.辛伐他汀抑制K562细胞MAPK1、cyclin D1、E2F1、c-myc mRNA的表达[J].第三军医大学学报,2009,31(03):241. YANG Yong-chang,CHUAN Liang-min,HUANG Wen-fang,et al.Simvastatin down-regulates mRNA expressions of MAPK1, cyclin D1, E2F1 and c-myc in K562 cells[J].J Third Mil Med Univ,2009,31(18):241. [2]舒燕,齐杰玉,王灿蔚,等.MicroRNA-193b对K562细胞bcr/abl表达的影响[J].第三军医大学学报,2015,37(19 ):1955. Shu Yan,Qi Jieyu,Wang Canwei,et al.MicroRNA-193b down-regulates bcr/abl in K562 cells[J].J Third Mil Med Univ,2015,37(18):1955. [3]周定安,黄文芳,刘文,等.P53途径在辛伐他汀诱导K562细胞凋亡中的作用[J].第三军医大学学报,2007,29(22):2160. ZHOU Ding-an,HUANG Wen-fang,LIU Wen,et al.Role of P53 pathway in simvastatin-induced apoptosis of K562 cells in vitro[J].J Third Mil Med Univ,2007,29(18):2160. [4]周定安,黄文芳,张明川,等.辛伐他汀对K562细胞PI3K-AKT信号通路分子变化影响的体内外比较[J].第三军医大学学报,2007,29(21):2049. ZHOU Ding-an,HUANG Wen-fang,ZHANG Ming-chuan,et al.Molecular changes of PI3K-AKT signal pathway in K562 cells treated with simvastatin in vitro and in vivo[J].J Third Mil Med Univ,2007,29(18):2049. [5]袁媛,李招权,司维柯,等.Wnt5a与髓细胞白血病发生关系的研究[J].第三军医大学学报,2007,29(21):2056. YUAN Yuan,LI Zhao-quan,SI Wei-ke,et al.Correlation between myeloid leukemia development and Wnt5a expression[J].J Third Mil Med Univ,2007,29(18):2056. [6]李招权,司维柯,邹全明,等.外源性Wnt5a激活K562细胞非经典Wnt5a/Ca2+信号途径研究[J].第三军医大学学报,2008,30(10):924. LI Zhao-quan,SI Wei-ke,ZOU Quan-ming,et al.Noncanonical Wnt5a/Ca2+ pathway activated by exogenous Wnt5a in K562 cells[J].J Third Mil Med Univ,2008,30(18):924. [7]何鹏,骆展鹏,张伶,等.RNAi重组体抑制白血病K562细胞系中NPM1基因的表达[J].第三军医大学学报,2008,30(10):938. HE Peng,LUO Zhan-peng,ZHANG Ling,et al.RNA interference silencing nucleophosmin 1 inhibits NPM1 gene expression in K562 cells[J].J Third Mil Med Univ,2008,30(18):938. [8]林雪梅,田雪莲,杨慧,等.青蒿琥酯对K562细胞和脐血CD34+造血干/祖细胞的选择性作用[J].第三军医大学学报,2007,29(20):1939. LIN Xue-mei,TIAN Xue-lian,YANG Hui,et al.Selective effect of artesunate on K562 cell and CD34+ hematopoietic stem/progenitor cell from umbilical cord blood[J].J Third Mil Med Univ,2007,29(18):1939. [9]罗颖,温贤浩,徐酉华.K562细胞survivin基因表达对淋巴细胞增殖和功能的影响[J].第三军医大学学报,2008,30(23):2215. LUO Ying,WEN Xian-hao,XU You-hua.Effect of enhanced survivin expression on lymphocyte proliferation and function in K562 cells[J].J Third Mil Med Univ,2008,30(18):2215. [10]史梅,冯文莉,王小中,等.靶向阻断STAT5对白血病K562细胞周期的影响[J].第三军医大学学报,2005,27(21):2118.
